Crescent Capital BDC (CCAP) to Post Quarterly Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) is expected to be issuing its Q2 2026 results after the market closes on Monday, August 10th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $37.1170 million for the quarter. Investors can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 12:00 PM ET.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last announced its earnings results on Wednesday, May 13th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The company had revenue of ($6.83) million during the quarter, compared to analysts’ expectations of $39.58 million. Crescent Capital BDC had a net margin of 9.26% and a return on equity of 9.34%. On average, analysts expect Crescent Capital BDC to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Crescent Capital BDC Price Performance

Shares of CCAP stock traded up $0.16 during trading hours on Monday, hitting $11.09. The company’s stock had a trading volume of 40,224 shares, compared to its average volume of 221,744. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 1.35. The business has a fifty day moving average of $11.15 and a 200-day moving average of $12.53. Crescent Capital BDC has a twelve month low of $10.64 and a twelve month high of $16.03. The stock has a market cap of $408.59 million, a price-to-earnings ratio of 27.05 and a beta of 0.52.

Crescent Capital BDC Dividend Announcement

The business also recently announced a special dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, November 30th will be issued a dividend of $0.03 per share. This represents a yield of 107.0%. The ex-dividend date is Monday, November 30th. Crescent Capital BDC’s dividend payout ratio is 331.71%.

Insider Transactions at Crescent Capital BDC

In related news, President Henry Chung bought 4,500 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was purchased at an average cost of $11.45 per share, for a total transaction of $51,525.00. Following the completion of the acquisition, the president owned 20,722 shares in the company, valued at $237,266.90. This trade represents a 27.74% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jason Breaux purchased 5,000 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were bought at an average cost of $11.19 per share, for a total transaction of $55,950.00. Following the purchase, the chief executive officer owned 52,636 shares of the company’s stock, valued at $588,996.84. This trade represents a 10.50% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 1.23% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. North Ground Capital lifted its stake in shares of Crescent Capital BDC by 99.8% in the 4th quarter. North Ground Capital now owns 835,312 shares of the company’s stock valued at $11,736,000 after purchasing an additional 417,312 shares in the last quarter. Invesco Ltd. increased its position in Crescent Capital BDC by 1,504.9% during the 4th quarter. Invesco Ltd. now owns 659,696 shares of the company’s stock worth $9,269,000 after purchasing an additional 618,590 shares in the last quarter. Franklin Resources Inc. raised its holdings in Crescent Capital BDC by 7.0% in the third quarter. Franklin Resources Inc. now owns 540,460 shares of the company’s stock valued at $7,707,000 after buying an additional 35,534 shares during the period. Bulldog Investors LLP lifted its position in Crescent Capital BDC by 4.6% during the fourth quarter. Bulldog Investors LLP now owns 457,518 shares of the company’s stock valued at $6,428,000 after buying an additional 20,000 shares in the last quarter. Finally, Mariner LLC grew its stake in Crescent Capital BDC by 0.3% during the fourth quarter. Mariner LLC now owns 451,774 shares of the company’s stock worth $6,369,000 after buying an additional 1,492 shares during the period. Institutional investors and hedge funds own 49.46% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CCAP. Wall Street Zen cut Crescent Capital BDC from a “hold” rating to a “sell” rating in a report on Saturday, July 25th. Zacks Research raised shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 21st. Wells Fargo & Company reduced their target price on shares of Crescent Capital BDC from $13.00 to $12.00 and set an “equal weight” rating on the stock in a report on Friday, May 15th. Oppenheimer cut shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $19.00 to $16.00 in a research note on Friday, May 15th. Finally, B. Riley Financial reiterated a “neutral” rating on shares of Crescent Capital BDC in a report on Friday, May 15th. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $13.90.

Read Our Latest Research Report on Crescent Capital BDC

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.

See Also

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.